Threshold is a biotechnology company focused on the discovery and development of therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional drugs.
Recent News
May 9, 2013
Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences
May 2, 2013
Threshold Pharmaceuticals Reports First Quarter 2013 Financial and Operational Results
April 25, 2013
Threshold Pharmaceuticals Announces Presentation and Webcast at the 12th Annual Needham Healthcare Conference
View All Recent NewsEvents
June 6, 2013
Jefferies 2013 Global Healthcare Conference
New York, NY
May 22, 2013
2013 UBS Global Healthcare Conference
New York, NY
May 15, 2013
Bank of America Merrill Lynch 2013 Health Care Conference
Las Vegas, NV
April 30, 2013
12th Annual Needham Healthcare Conference
New York, NY
